AOL

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

Federal regulators are grappling with a significant backlog of factory inspections for drug manufacturing, with many facilities not reviewed since before the pandemic. An analysis by The Associated ...
Northwest Arkansas Democrat Gazette

FDA’s inspections still lag pre-pandemic period

WASHINGTON -- Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the covid-19 pandemic upended factory ...
MM&M

FDA layoffs could compromise safety of medications made at foreign factories, inspectors say

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.
Newsweek

COVID Delays Leave Nearly 2,000 Drug Plants Behind on Inspections: Report

Nearly 2,000 drug plants have still not been inspected since the COVID-19 pandemic halted global factory checks, an investigation by The Associated Press (AP) found. The AP reported on Thursday that ...